Results 131 to 140 of about 28,637 (186)
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2). [PDF]
Navas-Acien A +18 more
europepmc +1 more source
The Diagnostic Performance of Serum Glycosylated Ferritin in Patients Undergoing Regular Blood Transfusion: An Indicator of Iron Overload to Initiate Iron Chelation Therapy. [PDF]
Shrivastava A, Kumari S, Mohapatra S.
europepmc +1 more source
Chelation Therapy in Iron Poisoning [PDF]
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chelation Therapy of Atherosclerosis
Drug Intelligence & Clinical Pharmacy, 1984Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptable evidence supporting chelation therapy for atherosclerotic vascular disease is lacking.
Larry K Golightly
exaly +3 more sources
Combined iron chelation therapy [PDF]
Patients with thalassemia major accumulate body iron over time as a consequence of continuous red blood cell transfusions which cause hepatic, endocrine, and cardiac complications. Despite the availability of three iron chelators, some patients fail to respond adequately to monotherapy with any of them. Combination therapy, consisting in the use of two
Galanello Renzo +5 more
openaire +3 more sources
Kill or cure: Misuse of chelation therapy for human diseases [PDF]
Chelation therapy is a consolidated medical procedure used primarily to reduce the toxic effects of metal ions on human tissues. Its application spans a broad spectrum of disorders, ranging from acute metal intoxication to genetic metal-overload. The use
Maria Antonietta Zoroddu +2 more
exaly +4 more sources
Chelation therapy in cardiovascular disease: an update [PDF]
INTRODUCTION: The off-label use of chelation therapy (disodium edetate or EDTA) for prevention of cardiovascular disease (CVD) is widespread, despite the lack of convincing evidence for efficacy or approval from the Food and Drug Administration.
, , Farouk Mookadam
exaly +2 more sources

